the fda is keeping a bold - letter warning on pfizer 's anti-smoking drug chantix about suicidal behavior and other psychiatric side effects
the tablet has carried the fda 's strongest warning label since 2009
that followed reports of suicidal tendencies and violent or bizarre behavior among some patients
the fda on monday outlined several updates to chantix 's labeling , including a new warning about its potential interaction with alcohol
some patients have reported unusual or aggressive behavior when drinking while on chantix